• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Characteristics of COVID-19 disease in multiple sclerosis patients.多发性硬化症患者的新冠肺炎疾病特征
Mult Scler Relat Disord. 2020 Oct;45:102276. doi: 10.1016/j.msard.2020.102276. Epub 2020 Jun 8.
2
Multiple sclerosis following SARS-CoV-2 infection.感染 SARS-CoV-2 后出现多发性硬化症。
Mult Scler Relat Disord. 2020 Oct;45:102377. doi: 10.1016/j.msard.2020.102377. Epub 2020 Jul 7.
3
Response of the multiple sclerosis community to COVID-19.多发性硬化症群体对2019冠状病毒病的反应。
Mult Scler. 2020 Sep;26(10):1134-1136. doi: 10.1177/1352458520948748.
4
Neuropsychiatric and cognitive effects of the COVID-19 outbreak on multiple sclerosis patients.新冠疫情对多发性硬化症患者的神经精神和认知影响。
Mult Scler Relat Disord. 2020 Jun;41:102164. doi: 10.1016/j.msard.2020.102164. Epub 2020 Apr 29.
5
Multiple sclerosis and COVID-19.多发性硬化症与2019冠状病毒病
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2020 Sep;164(3):217-225. doi: 10.5507/bp.2020.033. Epub 2020 Jul 17.
6
The COVID-19 pandemic and the use of MS disease-modifying therapies.新冠疫情与多发性硬化症疾病修正疗法的使用
Mult Scler Relat Disord. 2020 Apr;39:102073. doi: 10.1016/j.msard.2020.102073. Epub 2020 Mar 27.
7
Evaluation of the Level of Anxiety among Iranian Multiple Sclerosis Fellowships During the Outbreak of COVID-19.新冠疫情期间伊朗多发性硬化症患者群体焦虑水平评估
Arch Iran Med. 2020 Apr 1;23(4):283. doi: 10.34172/aim.2020.13.
8
COVID-19 and high-efficacy multiple sclerosis therapies: Time for business as usual?新型冠状病毒肺炎与高效多发性硬化症疗法：一切照旧的时候到了吗？
Mult Scler. 2020 Sep;26(10):1267. doi: 10.1177/1352458520948211. Epub 2020 Aug 7.
9
COVID-19 and Telepsychiatry in Iran.伊朗的新冠肺炎与远程精神病学
Prim Care Companion CNS Disord. 2020 Oct 22;22(5):20com02786. doi: 10.4088/PCC.20com02786.
10
Treatment of multiple sclerosis under the COVID-19 pandemic.新冠疫情下的多发性硬化症治疗
Tidsskr Nor Laegeforen. 2020 Apr 29;140(8). doi: 10.4045/tidsskr.20.0333. Print 2020 May 26.

引用本文的文献

1
Fear of re-infection, relapse, and anxiety during COVID-19 pandemic in patients with multiple sclerosis: A multi-center study.多发性硬化症患者在新冠疫情期间对再次感染、复发及焦虑的恐惧：一项多中心研究。
Curr J Neurol. 2023 Apr 4;22(2):82-86. doi: 10.18502/cjn.v22i2.13332.
2
Change in the air due to the coronavirus outbreak in four major cities of India: What do the statistics say?印度四大城市因新冠疫情爆发导致的空气质量变化：统计数据说明了什么？
J Hazard Mater Adv. 2023 May;10:100325. doi: 10.1016/j.hazadv.2023.100325. Epub 2023 May 29.
3
Severe outcomes of COVID-19 among patients with multiple sclerosis under anti-CD-20 therapies: A systematic review and meta-analysis.抗 CD-20 治疗的多发性硬化症患者 COVID-19 的严重结局：系统评价和荟萃分析。
Mult Scler Relat Disord. 2022 Jan;57:103358. doi: 10.1016/j.msard.2021.103358. Epub 2021 Nov 5.
4
Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies.多发性硬化症患者 COVID-19 相关死亡率的决定因素：观察性研究的荟萃回归分析。
J Neurol. 2022 May;269(5):2275-2285. doi: 10.1007/s00415-021-10951-6. Epub 2022 Jan 4.
5
Increased risk of death from COVID-19 in multiple sclerosis: a pooled analysis of observational studies.COVID-19 导致多发性硬化症患者死亡风险增加：一项观察性研究的汇总分析。
J Neurol. 2022 Mar;269(3):1114-1120. doi: 10.1007/s00415-021-10803-3. Epub 2021 Sep 17.
6
Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations.多发性硬化症、疾病修正疗法与2019冠状病毒病：关于免疫反应和疫苗接种建议的系统综述
Vaccines (Basel). 2021 Jul 11;9(7):773. doi: 10.3390/vaccines9070773.
7
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement.COVID-19 大流行期间和大流行后多发性硬化症的管理更新：国际共识声明。
J Neuroimmunol. 2021 Aug 15;357:577627. doi: 10.1016/j.jneuroim.2021.577627. Epub 2021 Jun 7.
8
The prevalence of COVID-19 infection in patients with multiple sclerosis (MS): a systematic review and meta-analysis.COVID-19 感染在多发性硬化症（MS）患者中的流行情况：系统评价和荟萃分析。
Neurol Sci. 2021 Aug;42(8):3093-3099. doi: 10.1007/s10072-021-05373-1. Epub 2021 Jun 7.
9
Registry of patients with multiple sclerosis and COVID-19 infection in Saudi Arabia.沙特阿拉伯多发性硬化症和 COVID-19 感染患者登记册。
Mult Scler Relat Disord. 2021 Jul;52:103004. doi: 10.1016/j.msard.2021.103004. Epub 2021 May 7.
10
COVID-19 Among Patients With Multiple Sclerosis: A Systematic Review.COVID-19 与多发性硬化症患者：一项系统综述。
Neurol Neuroimmunol Neuroinflamm. 2021 May 20;8(4). doi: 10.1212/NXI.0000000000001001. Print 2021 Jul.

本文引用的文献

1
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemic.一名多发性硬化症患者在大流行期间开始使用奥瑞珠单抗治疗，感染新冠病毒后预后良好。
Mult Scler Relat Disord. 2020 Aug;43:102222. doi: 10.1016/j.msard.2020.102222. Epub 2020 May 23.
2
B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.B 细胞耗竭疗法可能会影响伊朗 COVID-19 疫情早期多发性硬化症患者急性呼吸道疾病的易感性。
Mult Scler Relat Disord. 2020 Aug;43:102195. doi: 10.1016/j.msard.2020.102195. Epub 2020 May 13.
3
A fine balance: Immunosuppression and immunotherapy in a patient with multiple sclerosis and COVID-19.微妙的平衡：免疫抑制与免疫疗法在多发性硬化合并 COVID-19 患者中的应用。
Mult Scler Relat Disord. 2020 Jul;42:102182. doi: 10.1016/j.msard.2020.102182. Epub 2020 May 8.
4
Severe COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.多发性硬化症患者在接受芬戈莫德治疗后感染严重 COVID-19。
Mult Scler Relat Disord. 2020 Jul;42:102180. doi: 10.1016/j.msard.2020.102180. Epub 2020 May 6.
5
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain.多发性硬化症及相关疾病中的抗CD20与COVID-19：来自西班牙马德里的60例患者病例系列
Mult Scler Relat Disord. 2020 Jul;42:102185. doi: 10.1016/j.msard.2020.102185. Epub 2020 May 7.
6
COVID-19 infection in a patient with multiple sclerosis treated with fingolimod.一名接受芬戈莫德治疗的多发性硬化症患者感染了新冠病毒。
Neurol Neuroimmunol Neuroinflamm. 2020 May 5;7(4). doi: 10.1212/NXI.0000000000000753. Print 2020 Jul.
7
Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis.早发型和晚发型多发性硬化与成人型多发性硬化的临床特征及残疾进展比较
J Clin Med. 2020 May 2;9(5):1326. doi: 10.3390/jcm9051326.
8
An Italian programme for COVID-19 infection in multiple sclerosis.一项针对多发性硬化症患者新冠病毒感染情况的意大利项目。
Lancet Neurol. 2020 Jun;19(6):481-482. doi: 10.1016/S1474-4422(20)30147-2. Epub 2020 Apr 30.
9
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区，5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
10
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?奥瑞珠单抗治疗多发性硬化症患者合并 COVID-19：免疫抑制是否具有保护作用？
Mult Scler Relat Disord. 2020 Jul;42:102120. doi: 10.1016/j.msard.2020.102120. Epub 2020 Apr 15.

Characteristics of COVID-19 disease in multiple sclerosis patients.

作者信息

Barzegar Mahdi, Mirmosayyeb Omid, Ghajarzadeh Mahsa, Nehzat Nasim, Vaheb Saeed, Shaygannejad Vahid, Vosoughi Reza

机构信息

Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran; Department of Neurology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran; Universal Council of Epidemiology (UCE) Universal Scientific Education and Research Network (USERN), Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Mult Scler Relat Disord. 2020 Oct;45:102276. doi: 10.1016/j.msard.2020.102276. Epub 2020 Jun 8.

DOI:10.1016/j.msard.2020.102276
PMID:32652473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7278648/
Abstract
摘要